Simplify Propel Opportunities ETF Rating $19.10 +0.28 (+1.49%) As of 02:56 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SURI Aggregate RatingModerate Buy 2.59Holdings in SURI have an aggregate rating of Moderate Buy based on 181 analyst ratings issued in the past year covering 21 companies (92.6% of the portfolio).SURI Aggregate Price Target$19.10High Prediction$19.10Average Prediction$19.10Low Prediction$19.10Holdings in SURI have an aggregate price target of $19.10 and a range of $19.10 to $19.10 covering 21 companies (92.6% of the portfolio).SURI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Propel Opportunities ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 SURI Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings43.15%PAGPPlains GP$25.84+1.4%2.295 of 5 stars2.31$23.36 -9.6%13Dividend Announcement11.84%ACHVAchieve Life Sciences$7.58+4.5%2.4938 of 5 stars3.00$15.00 98.0%8News CoverageEarnings ReportAnalyst ForecastAnalyst Revision4.79%MISTMilestone Pharmaceuticals$1.10+2.3%1.6993 of 5 stars2.67$7.25 562.1%6Trending NewsEarnings ReportAnalyst Revision4.11%DCTHDelcath Systems$16.76-3.4%3.7841 of 5 stars2.86$23.17 38.2%7Analyst Revision3.90%CORTCorcept Therapeutics$114.53+3.6%2.7753 of 5 stars2.63$119.17 4.1%8Positive NewsInsider Trade3.24%CASHPathward Financial$86.58+0.5%4.2664 of 5 stars3.00$101.00 16.7%32.81%PHATPhathom Pharmaceuticals$9.58+4.3%3.2615 of 5 stars2.88$23.43 144.7%82.60%CLDXCelldex Therapeutics$41.93-1.6%2.9158 of 5 stars2.86$55.46 32.3%14Analyst Revision2.28%ABEOAbeona Therapeutics$5.99-5.6%3.1681 of 5 stars2.33$19.33 223.0%3Trending NewsEarnings ReportAnalyst ForecastGap DownHigh Trading Volume1.81%IVAInventiva$4.60-0.1%2.9462 of 5 stars3.09$16.56 260.3%11Positive News1.72%KYTXKyverna Therapeutics$8.19+1.3%2.5999 of 5 stars2.67$30.00 266.3%6Trending NewsEarnings ReportAnalyst Revision1.67%CMPSCompass Pathways$13.46+1.2%2.6895 of 5 stars2.88$23.36 73.6%17Analyst Revision1.36%LONAAthira Pharma$7.98+1.4%3.8035 of 5 stars2.50$16.00 100.5%61.33%AQSTAquestive Therapeutics$4.28+0.6%2.3602 of 5 stars3.00$8.50 98.8%7News CoverageEarnings Report1.32%ARTVArtiva Biotherapeutics$11.45+1.4%2.8179 of 5 stars2.83$39.00 240.5%6Analyst Revision1.12%OBIOOrchestra BioMed$4.40-1.0%4.2635 of 5 stars2.63$13.00 195.2%8Earnings ReportAnalyst ForecastAnalyst RevisionGap Down1.06%PALIPalisade Bio$2.14-0.7%3.1625 of 5 stars3.00$9.00 321.5%10Earnings ReportAnalyst Revision0.85%OCULOcular Therapeutix$10.05-0.5%3.1311 of 5 stars2.77$25.75 156.1%13Analyst Upgrade0.61%EYPTEyepoint Pharmaceuticals$14.70+9.0%2.3703 of 5 stars2.89$44.38 202.0%9Options VolumeGap Up0.55%IMUXImmunic$15.94-3.9%2.7993 of 5 stars3.00$47.57 198.5%11Positive NewsEarnings Report0.50%UPBUpstream Bio$7.08+2.5%1.9408 of 5 stars2.43$29.67 319.0%7Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision This page (NYSEARCA:SURI) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredBarricks gold output fell from 2 million ounces to 719000Barrick's gold production has plunged from 2 million ounces to just 719,000, leaving the world's second-larges...Golden Portfolio | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Propel Opportunities ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Propel Opportunities ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
